Rolf Bjerkvig
Affiliations: | The Department of biomedicine | University of Bergen, Norway, Bergen, Hordaland, Norway |
Website:
https://www.uib.no/en/persons/Rolf.BjerkvigGoogle:
"Rolf Bjerkvig"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Guyon J, Fernandez-Moncada I, Larrieu CM, et al. (2022) Lactate dehydrogenases promote glioblastoma growth and invasion via a metabolic symbiosis. Embo Molecular Medicine. e15343 |
Fabian C, Han M, Bjerkvig R, et al. (2021) Novel facets of glioma invasion. International Review of Cell and Molecular Biology. 360: 33-64 |
Lingasamy P, Tobi A, Kurm K, et al. (2020) Tumor-penetrating peptide for systemic targeting of Tenascin-C. Scientific Reports. 10: 5809 |
Biedermann J, Preussler M, Conde M, et al. (2019) Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin. Cancers. 11 |
Feng Z, Zhou W, Wang J, et al. (2019) Reduced expression of proteolipid protein 2 increases ER stress-induced apoptosis and autophagy in glioblastoma. Journal of Cellular and Molecular Medicine |
Han M, Wang S, Yang N, et al. (2019) Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma. Embo Molecular Medicine. e10924 |
Ji J, Ding K, Luo T, et al. (2019) PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1. Oncogene |
Aasen SN, Espedal H, Holte CF, et al. (2019) Improved drug delivery to brain metastases by peptide-mediated permeabilization of the blood-brain barrier. Molecular Cancer Therapeutics |
Dirkse A, Golebiewska A, Buder T, et al. (2019) Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment. Nature Communications. 10: 1787 |
Hossain JA, Latif MA, Ystaas LAR, et al. (2019) Long-term treatment with valganciclovir improves lentiviral suicide gene therapy of glioblastoma. Neuro-Oncology |